Infusional chemotherapy combined with recombinant human granulocyte colony stimulating factor: advantages and limitations.
about
Pegfilgrastim on the Same Day Versus Next Day of Chemotherapy in Patients With Breast Cancer, Non-Small-Cell Lung Cancer, Ovarian Cancer, and Non-Hodgkin's Lymphoma: Results of Four Multicenter, Double-Blind, Randomized Phase II Studies.Effectiveness of cytopenia prophylaxis for different filgrastim and pegfilgrastim schedules in a chemotherapy mouse model.
P2860
Infusional chemotherapy combined with recombinant human granulocyte colony stimulating factor: advantages and limitations.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Infusional chemotherapy combin ...... r: advantages and limitations.
@en
type
label
Infusional chemotherapy combin ...... r: advantages and limitations.
@en
prefLabel
Infusional chemotherapy combin ...... r: advantages and limitations.
@en
P1476
Infusional chemotherapy combin ...... r: advantages and limitations.
@en
P2093
P356
10.1097/00000421-199702000-00014
P577
1997-02-01T00:00:00Z